🔎 Trials Near Me

Početna › Tumori mozga › Michigan

Kliničke studije za Tumori mozga u državi Michigan

19 studija za Tumori mozga traži sudionike na lokacijama u državi Michigan.

Gradovi u državi Michigan

Službeni tekst studije (engleski)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Henry Ford Cancer- Detroit, Detroit
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07326566

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT05786924

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0119, Ann Arbor
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
  • Bronson Battle Creek, Battle Creek
  • University of Michigan - Brighton Center for Specialty Care, Brighton
  • i još 15
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 2
59 Months · Oba spola · Ažurirano 15. ruj 2026. · NCT05535166

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • University of Michigan, Ann Arbor
  • Henry Ford Cancer Institute, Detroit
  • START - Midwest Cancer Research Center, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06253871

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Henry Ford Hospital, Detroit
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT05386108

Targeted Pediatric High-Grade Glioma Therapy

  • C.S. Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaOpažajna studija
12 Months – 39 Years · Oba spola · Ažurirano 8. ruj 2026. · NCT05839379

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

  • Karmanos Cancer Institute, Detroit
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06136884

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  • Henry Ford Health System, Detroit
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 22. srp 2026. · NCT04427384

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
U tijeku regrutacijaFaza 1
Od 3 do 39 godina · Oba spola · Ažurirano 15. lip 2026. · NCT06914479

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • University of Michigan Rogel Cancer Center, Ann Arbor
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. lip 2026. · NCT03550391

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • C.S. Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaFaza 2
12 Months – 39 Years · Oba spola · Ažurirano 29. svi 2026. · NCT05843253

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

  • Henry Ford, Detroit
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. tra 2026. · NCT04222062

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

  • C.S. Mott Children's Hospital, University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 1
Od 4 do 25 godina · Oba spola · Ažurirano 5. ožu 2026. · NCT04510051

F-Tryptophan PET/CT in Human Cancers

  • Karmanos Cancer Institute, Detroit
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. sij 2026. · NCT05556473

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

  • Henry Ford Health System, Detroit
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 16. pro 2025. · NCT05686798

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

  • University of Michigan Health Sparrow, Lansing
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 5. stu 2025. · NCT07225101

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Saint Joseph Mercy Hospital, Ann Arbor
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
  • McLaren Cancer Institute-Bay City, Bay City
  • i još 16
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. lis 2025. · NCT03418961

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.